Breast cancer treatment 'not value for money' WebMD.Boots.com 21st March 2013 - Provisional draft guidance by the National Institute for Health and Clinical Excellence (NICE) does not recommend the drug everolimus (Afinitor) as an NHS-funded treatment for HER2 negative, hormone-receptor-positive advanced breast ... |
